Robert B. Livingston

Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer

Timothy Winton, Robert B. Livingston, David C. Johnson et al. · New England Journal of Medicine · 2005 · 1.8K citations · Full text

Medicine, Oncology, Pharmacology +16

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741

Marc L. Citron, Donald A. Berry, Constance Cirrincione et al. · Journal of Clinical Oncology · 2003 · 1.6K citations

Medicine, Oncology, Pharmacology +15

Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide

Andrew T. Turrisi, KyungMann Kim, Ronald H. Blum et al. · New England Journal of Medicine · 1999 · 1.5K citations · Full text

Medicine, Oncology, Radiation Oncology +11

Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial

Kathy S. Albain, Ruth Swann, Valerie W. Rusch et al. · The Lancet · 2009 · 1.5K citations

Medicine, Oncology, Surgery +16

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

Kathy S. Albain, William E. Barlow, Steven Shak et al. · The Lancet Oncology · 2009 · 1.4K citations · Full text

Medicine, Oncology, Breast Oncology +12